Domains of quality for clinical ethics case consultation: a mixed-method systematic review by unknown
PROTOCOL Open Access
Domains of quality for clinical ethics case
consultation: a mixed-method systematic
review
Louis Leslie1,5*, Rebecca Frances Cherry2, Abbas Mulla1, Jean Abbott3, Kristin Furfari1, Jacqueline J. Glover3,
Benjamin Harnke4 and Matthew K. Wynia1,3
Abstract
Background: “Clinical ethics consultation” (CEC) is the provision of consultative services by an individual or team
with the aim of helping health professionals, patients, and their families grapple with difficult ethical issues arising
during health care. There are almost 25,000 articles in the worldwide literature on CEC, but very few explicitly
address measuring the quality of CEC. Many more address quality implicitly, however. This article describes a
rigorous protocol for compiling the diverse literature on CEC, analyzing it with a quality measurement lens, and
seeking a set of potential quality domains for CEC based on areas of existing, but hitherto unrecognized, consensus
in the literature.
Methods/design: This mixed-method systematic review will follow a sequential pattern: scoping review, qualitative
synthesis, and then a quantitative synthesis. The scoping review will include categorizing all quality measures for
CEC discussed in the literature, both quantitative and qualitative. The qualitative synthesis will generate a
comprehensive analytic framework for understanding the quality of CEC and is expected to inform the quantitative
synthesis, which will be a meta-analysis of studies reporting the effects of CEC on pre-specified clinical outcomes.
Discussion: The literature on CEC is broad and diverse and has never been examined with specific regard to
quality measurement. We propose a novel mixed-methods approach to compile and synthesize this literature and
to derive a framework for assessing quality in CEC.
Systematic review registration: PROSPERO CRD42015023282
Keywords: Clinical ethics, Health care ethics committees, Ethics consultation, Mixed-method, Scoping review,
Bioethics, Systematic review
Background
The ethics of health care delivery are famously complex.
While classical principles of medical ethics such as ben-
eficence, justice, and autonomy can provide some guid-
ance, how are health professionals to decide when an
action that may be beneficial conflicts with obligations
to justice or to respecting patient autonomy? To help
health professionals, patients, and their families navigate
such challenging questions, the field of clinical ethics
consultation was born [1, 2].
The American Society for Bioethics and Humanities
(ASBH) defines clinical ethics consultation (CEC) as “a ser-
vice provided by an individual or a group to help patients,
families, surrogates, health care providers, or other involved
parties to address uncertainty or conflict regarding value-
laden issues that emerge in healthcare.” [2] These services
have been part of most hospitals’ operations for more than
20 years [1]. In 1983, Younger et al. found that only 1 % of
hospitals in the USA reported having an ethics committee
[3], but by 1998, over 90 % of US hospitals had created
ethics committees [4, 5]. This burgeoning growth was
stimulated in part by a 1992 requirement of The Joint
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Commission (TJC) that hospitals develop a “mechanism” to
help teams address ethical dilemmas in the care of hospital-
ized patients [6].
This rapid increase in clinical ethics committees, both
in the USA and abroad, has naturally led to discussions
about how to define and measure the quality of the CEC
services they provide [7–15]. Much debate has ensued
about how, or even if, CEC services can be evaluated
and what elements are most critical [16].
To develop tools to measure quality of CEC, an analyt-
ical model must first be developed that describes the
basic aims of these consultations. Creating such a model
de novo can be thought of as analogous to developing a
new survey tool: it should start with focus groups and
structured interviews in the community of interest, to
craft the language and concepts that the survey tool will
eventually try to measure. Similarly, to better understand
the common language and concepts of quality in CEC,
we propose to use the broad field of literature related to
CEC as our community information source, with quali-
tative and quantitative analysis of this literature as ana-
logues to focus groups and structured interviews.
To our knowledge, no formal systematic review of the
literature around CEC has been conducted that aimed to
list possible CEC quality measures or to derive a set of
general categories of such measures (i.e., CEC quality
domains). We are therefore planning to carry out a
structured, in-depth examination of the literature ad-
dressing CEC quality using a sequential mixed-method
approach [17, 18], which will proceed in three phases as
described below.
If we find reasonable levels of consensus within the lit-
erature around some of the quality measures or domains
derived from the proposed approach, these might then
serve as a starting point for the development of uniform
quality measures for CEC services. Having a consensus
set of CEC quality domains and measures might also
contribute toward the continued evolution of CEC prac-
tice guidelines [19, 20] and could inform ongoing discus-
sions about the professionalization of the field.
Objectives
This review has three primary objectives:
1. List the quality measures of CEC found in the
literature—scoping review
2. Develop an analytical structure for measuring the
quality of CEC—qualitative synthesis
3. Assess the effects of CEC on clinical and other
outcomes—quantitative synthesis
Our initial probe of the literature found around 28,000
articles that touch on CEC. Based on an initial scan of
titles and abstracts, we estimate that roughly 4000 are
likely to include some specific discussion of quality and
meet other inclusion criteria, as shown in Fig. 1. The
figure also shows the basic outline of our structured,
mixed-methods approach to this project.
Phase I will be a scoping review, using comprehensive
literature review methods as detailed below [21]. In brief,
we will use a rigorous search strategy and categorize to
organize the literature on CEC as it pertains to quality
measurement. This serves a two-fold purpose of (1)
compiling the literature needed for the next two phases
and (2) creating a preliminary list of potential quality
measures that will be used to help organize our work in
subsequent phases and which may also be useful for
other researchers in this field.
Phase II will be a formal synthesis of the qualitative lit-
erature on CEC quality, looking for potentially measur-
able quality domains. This will follow the iterative
approach of a thematic analysis [22, 23] where multiple
ideas and conclusions across a body of literature are
summarized into key themes, which are then refined
into categories and sub-themes. It is these shared themes
that might then provide an analytical structure for meas-
uring the quality of CEC services.
Phase III will be a formal synthesis of studies assessing
the effects of CEC on pre-specified outcomes. We expect
this literature to be rather limited (Fig. 1), but we will use
meta-analytic methods if possible. If there is not sufficient
Fig. 1 Summary of mixed-method review
Leslie et al. Systematic Reviews  (2016) 5:95 Page 2 of 9
homogeneity in RCT methods and outcomes to perform a
meta-analysis, then we will produce a narrative summary
of the findings per standard practice [24, 25].
In a sequential mixed-method synthesis, the integra-
tion of qualitative and quantitative data typically occurs
in the final phase [17, 18], which is phase III (quantita-
tive synthesis) for our purposes. For example, the RCTs
we have found in our preliminary search, which will be
the subject of the phase III meta-analysis, have demon-
strated generally positive findings for CEC, but there are
pertinent study design differences that impact positive
outcomes. We expect to illuminate these key factors using
the derived analytical structure from phase II. Similarly,
we hope to show that consultation efficacy (effect size of
outcome measure, obtained in phase III) is a product of
consultation quality (using new measures derived from
the phase II qualitative synthesis).
Methods
Because there are three methodologically distinct phases to
this process, each will be described separately. As shown in
Fig. 1, the phases are dependent on each other but the
methods of each are unique. In particular, phase I will in-
clude the search function necessary for carrying out the
subsequent qualitative and quantitative syntheses. As de-
scribed below, data extraction, analysis, and findings will be
reported separately for each part of this mixed-method
synthesis.
Phase I (scoping review) methods
The aim for phase I is to compile the entire published
English language literature that relates directly to quality
measurement of CEC and to categorize this literature
into relevant study types, findings, and so on. This com-
prehensive scoping review of the literature will be per-
formed following the steps outlined by Arksey et al. [26].
Study inclusion and exclusion criteria
We will include all studies that reference any quality mea-
sures—whether of structure, process, or outcomes—of CEC,
whether implicitly or explicitly, and including but not lim-
ited to studies using the following methods: randomized-
controlled trial, cohort, case-control, cross-sectional, survey
studies, qualitative studies, case series, and non-research
analytic papers. In short, studies will not be excluded on the
basis of methodology or quality. Non-human studies will be
excluded, as will studies that describe only other non-
consultative activities of ethics committees (e.g., educational
outreach, research ethics consultations, policy development,
or organizational ethics work). Case studies and case series
addressing only bioethical content of consults will be ex-
cluded, but case studies or series will be included if they ad-
dress quality measurement related to structures, processes,
or outcomes of ethics consultation. Non-research analytic
articles will be included if they address quality measurement,
since opinions in these articles, taken together, can provide
guidance on how a complex intervention works, as has been
shown in other types of literature review [22, 27].
Types of participants
Included studies may address or examine any individuals
or groups involved in the ethics consultation process in
any of the eligible literature. This may include patients,
families, ethicists, health care workers, chaplains, lawyers,
and other stakeholders [8].
Types of interventions
The intervention under review is an ethics consultation
provided by an individual or team from an ethics con-
sultation service in a hospital or other health care deliv-
ery organization. In the USA, the process of CEC usually
includes a request for a consultation, assessment of that
request, ethical workup, recommendations, and then
documentation and potential follow-up [28]. This typical
process, however, is widely variable. Ethics case consult-
ation services can be provided by single individuals or
multi-person committees, volunteers or professionals,
and members of the community or employees, often
with great variation in education and certification (and
presumably, quality) [8, 29, 30]. Likewise, the consult-
ation itself can take many forms, from a phone call to a
full family gathering with an ethics committee, or a
retrospective discussion, where cases are reviewed fol-
lowing the consult [29]. Because ethics consultations
often involve multiple interactions over time rather than
being a single event, CEC using multiple methods are
common. [29] Publications addressing any of these types
of consultations will be included.
Types of outcomes
Primary outcomes A primary outcome of this phase
will be a comprehensive listing of potential measures
and domains of measurement (i.e., clusters of related
measures) for CEC. When considering measures and do-
mains of CEC quality, we will follow the Donabedian
Quality-of-Care Framework, which categorizes quality
measures as assessing structures, processes, or outcomes
[31]. This will not be the first time domains of quality
for an aspect of health care have been developed from
an examination of themes across a body of literature.
This project was inspired in part by the rise of quality im-
provement studies in health care, where the Donabedian
framework is frequently used to categorize measures of
health care quality into structural, process, and outcome
measures. These categories can also be used to inform the
development of quality measures [31]. Reviewing themes
across a body of literature is a particularly appropriate
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method for examining complex interventions in health
care. For example, the Institute of Medicine (IOM) has
used this same process to develop policy guidelines ad-
dressing what is and is not high-quality health care [32,
33]. Likewise, several members of our research team have
used this sort of step-wise thematic analysis to develop ar-
ticles, policy documents, and analytical instruments for
assessing other aspects of health care quality [19, 34–37].
Some examples of possible structure, process, and out-
come measures for CEC are as follows:
– Structural measures of quality assess such things
as institutional, provider, community, and client
characteristics: for CEC, these might include
measures of CEC accessibility (e.g., on-call
availability), consultant training, committee
composition, and staff support. [28, 29]
– Process measures of quality assess procedural
aspects of service delivery: for CEC, these might
include measures related to methods of service
delivery, number and type of interpersonal
interactions, timing of service delivery, and
communication methods used.
– Outcome measures of quality assess clinical, financial,
experiential, or other expected end-products of
receiving care: for CEC, these might include patient
satisfaction, conflict resolution, clinician satisfaction,
clinician learning, resource utilization, and changes in
staff moral distress or feelings of support [38–47].
Secondary outcomes As secondary outcomes, barriers
and facilitators to improved quality of CEC noted in the
literature will also be compiled.
Information sources and search methods
Ethics case consultations are complex interventions
intended to help address complex problems, and there
may be multiple components described in a given study
with contextual features dependent on factors including
study site and the perspectives of various involved stake-
holders. For this reason, our scoping review will be very
broadly inclusive. We will use the systematic and rigor-
ous Cochrane Collaboration standards, with one noted
exception: we will not use a trial-specific sensitive search
strategy [24]. This decision was based on our intent to
obtain the most comprehensive dataset possible to make
effect size comparisons in phase III, but it also serves
the purpose of providing a broad collection of literature
for our phase II qualitative synthesis. There has been
some argument in the literature about the challenges of
searching for qualitative literature [48, 49], so we may
adopt a more iterative process for that portion, as de-
scribed in phase II methods below.
To collect papers for inclusion, the authors will de-
velop a search strategy in tandem with an experienced li-
brarian (BH) using multiple thesaurus terms, keywords,
MESH terms, and appropriate truncations. A second,
unaffiliated librarian will validate this strategy using the
Peer Review of Electronic Search Strategies (PRESS)
protocol. [50] A draft Ovid MEDLINE search strategy is
included (see Additional file 1). The systematic search
strategy will begin with just two key terms: (1) clinical
ethics and (2) consultation. These are necessarily broad to
accomplish a proper scoping review. All references will be
uploaded into EndNote Reference Manager (EndNote X7,
Thomson Reuters, New York, NY, USA) and Distiller SR
(DSR) (Evidence Partners Incorporated, Ottawa, Canada),
where duplicates will be removed and recorded for Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) reporting [51–54]. A PRISMA-P
checklist for this protocol can be found in Additional file 2.
Electronic searches
We will use databases in medical science (Ovid MEDLINE,
Web of Science, EMBASE, Cochrane Collaboration, Joanna
Briggs Institute), ethics (ETHXWeb, JSTOR, Euroethics,
Endebit), law (LexisNexis, Westlaw International, Legal
Information Reference Center), arts and social sciences
(Psychology and Behavioral Sciences Collection, Campbell
Collaboration, PsychINFO, ERIC), and grey literature
(Academic Search Premier, ProQuest, Conference Proceed-
ings Citation Index-Science, Open Grey, PsychEXTRA,
EAGLE, NTIS NYAM Grey, Google Scholar, Google). All
databases will be searched from their inception without date
restrictions. There will be no geographic restrictions. Arti-
cles not in English will be excluded from this review due to
expense of translation fees. Articles without full text or with-
out available abstracts will be excluded if they cannot be ob-
tained from the authors following three email attempts.
Unpublished doctoral theses will be excluded.
Searching other resources
Two authors (LL, AM) will search a number of other
sources to further add to the literature for the scoping
review. Hand searching of key onsite journals (being
those that show up repeatedly in the electronic searches,
such as the Journal of Clinical Ethics, Healthcare Ethics
Forum, Hastings Center Reports, and the American
Journal of Bioethics) and pertinent book reference lists
will also be performed per Cochrane standards [24].
Electronic searches of conference proceedings (e.g.,
International Conference on Clinical Ethics Consult-
ation) and professional organizations (e.g., American
Society for Bioethics and Humanities) will be performed
to further add to the literature pool. References and
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citations of all included studies will be searched for
other potential literature.
Study records and data management
Literature search results will be saved in EndNote.
Collected literature will then be exported to DSR and
Nvivo11 (QSR International Pty Ltd., Doncaster, Australia).
For the textual analysis, two types of software will be used:
– The qualitative data analysis software Nvivo11 will
be used to evaluate textual information from the
quantitative studies.
– DSR, where title/abstract screening forms will be
used to calculate kappa. DSR may also be used to
create extraction forms, which will be used to note
demographic and numeric values and for
performing quality assessment for phase III.
Selection of studies
To select articles for inclusion, an electronic form will be
built in DSR, which will serve as a checklist of our inclu-
sion/exclusion criteria for initial title/abstract screening
and full-text screening. Two reviewers (LL, RC) will inde-
pendently review a random sample of 50 articles using the
level 1 inclusion/exclusion criteria form in DSR. Reviewers
will not be blinded to any portion of the article as this has
been shown to have little effect in protecting against bias
[55]. Inter-rater agreement for study inclusion will be cal-
culated using kappa statistics and percent agreement. This
process will be repeated until the reviewers have a mini-
mum of 90 % agreement. If issues or questions arise about
the inclusion/exclusion form, these will be discussed with
the other authors. If corrections are made, another round
of calibration will be performed until at least 90 % agree-
ment is obtained on the final form. Once there is 90 %
agreement on a form, LL and RC will begin independent
screening, with ongoing calculation of a kappa statistic.
Inclusion criteria will be deliberately broad simply asking
“Does this article pertain to CEC quality measurement,”
with responses being yes (include), no (exclude), and don’t
know (include). For the full text review phase, due to the
expected volume, the process will differ. All authors will
meet to review a set of full text articles for inclusion where
we will use the same question as the title/abstract screen-
ing, but only yes (include) and no (exclude) will be the
possible responses. This process will be repeated until at
least 90 % agreement is obtained. Following that, the re-
viewers (RC, AM, LL) will meet to repeat the calibration
exercise until 90 % agreement is obtained between them.
Following those two calibration steps, each reviewer (RC,
AM, LL) will independently review articles. If there are is-
sues or hesitations, they will be brought to the larger
group for discussion.
Assessment of risk of bias in included studies
For the scoping review, no assessment of bias or quality
appraisal will be made. Studies will not be excluded on
the basis of quality as the scoping review phase is about
categorizing the literature, not evaluating it or perform-
ing aggregative synthesis.
Data synthesis
The literature will be broadly categorized as to whether it
addresses quality measurement, including structure,
process or outcome measurement, barriers or facilitators
to effective consultation, etc. as well as general article in-
formation such as study design, country of origin, and
other descriptors that might help future researchers access
and use this literature. The product of this synthesis will
be a written summary with multiple tables and accom-
panying text of all the literature in the scoping review.
This product will then be brought to a diverse group
of stakeholders for review. This review phase will help to
assure the relevance of the summary report to the field-
at-large. For this, we will present our findings at regional
and national conferences, including a statewide group of
ethics consultants, including ethicists, lawyers, chaplains,
and other end-users. In presenting the results, we will
ask about the applicability, pertinence, and potential im-
pact of the findings. This informal stakeholder review
process will help inform the direction of the subsequent
mixed-method synthesis.
Phase II (qualitative synthesis) methods
Eligibility criteria
Because a comprehensive search will be executed for the
scoping review in phase I, the search criteria will not dif-
fer. All qualitative studies found in the scoping review
will be used for the phase II qualitative synthesis.
Search methods for identification of studies
No additional searching of the literature beyond that
found in the phase I search will be carried out except in
the unlikely event that theory saturation (i.e., the point
where the addition of new articles does not add new ex-
planatory theories) is not obtained in the course of the
data synthesis described below. This is highly unlikely
given the large number of studies anticipated to be
found in the initial search (Fig. 1).
Study records and data management
Three reviewers (LL, RC, AM) will perform an analysis
on included studies using the qualitative data analysis
software Nvivo11s to develop a thematic synthesis of the
literature, which is described in more detail in the “Data
Synthesis” section below.
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Selection of studies
All articles will have been categorized during the phase I
scoping review; all those categorized as qualitative arti-
cles pertaining to the measurement of quality of CEC
will be included in the phase II qualitative analysis. No
exclusions on the basis of quality will be made—articles
that may have poorly documented rigor may have con-
textually rich detail that contributes to the overall the-
matic analysis.
Assessment of risk of bias in included studies
No assessment of quality will be made during phase II.
The issue of quality appraisal of qualitative articles in sys-
tematic reviews is highly debated [56]. While there is a
current trend toward quality assessment, we did not feel it
was appropriate for this review, where relatively few em-
pirical studies are expected, where much of the work com-
prises essays, and where we are more concerned with the
views presented than their scientific rigor.
Data synthesis
This will follow the iterative approach of a thematic
analysis [22, 23] where multiple ideas and conclusions
across a body of literature are summarized into key
themes, which are then refined into categories and
sub-themes. This will proceed in three overlapping
stages:
1. Three reviewers (LL, RC, AM) will perform in vivo
coding (i.e., using direct quotes using the authors’
original language) of key quotes, metaphors, and
ideas from 30 articles selected at random. This will
facilitate the creation of an initial codebook of
directly extracted material. Using this codebook, all
of the included articles will be coded with standard
coding strategies in Nvivo11, highlighting concepts
and theories emphasized in the articles [57, 58].
2. The initial codebook will be analyzed for themes,
which will provide an organizing structure for related
areas. Initially, this will be done by further sub-coding
in Nvivo11. Comparisons of the groupings will be
performed by constant comparative analysis: main
theme from article A will be compared to article B, etc.
This will form a list of descriptive themes, which will
be the starting place for the next stage.
3. The descriptive themes from the above will be
further assessed to develop a set of “analytical”
themes, which will be the final product and
description of the quality domains of CEC. Methods
used in previous research by the authors may be
used to assist in analysis, including grouping and
clustering, vote counting, conceptual mapping, and
other qualitative analysis techniques. [22]. These
final product “analytical” themes will be used to
further elaborate on the quantitative synthesis and
scoping review.
These analytical themes will be presented in table format
with supporting text. This “summary of findings” will in-
clude the number of articles supporting each analytic
theme.
Phase III (quantitative synthesis) methods
Eligibility criteria
Because a comprehensive search will be executed for the
scoping review in phase I, the initial search criteria (popula-
tion, intervention, outcomes, etc.) will not differ. Instead,
randomized-controlled trials (RCTs) found in the scoping
review will be used for the quantitative synthesis. Non-
randomized controlled trials, prospective cohort, and
quasi-experimental studies will also be included, since there
are very few RCTs, but only if their outcomes and methods
are sufficiently similar to those in the RCTs. Subgroup ana-
lysis will be performed on any non-RCT studies included to
show different results according to study type.
Search methods for identification of studies
As noted, the scoping review search strategy is far more
comprehensive than a RCT-specific search would be and
includes both quantitative and qualitative studies. In
piloting electronic search strategies, we found that arti-
cles reporting on clinical trials were captured using our
broader search strategy as well as by the Cochrane
highly sensitive search strategy for identifying random-
ized trials [24]. For that reason, no specific additional lit-
erature searches will be carried out for phase III as the
entire search is considered to be complete.
Study records and data management
Initially, reviewers will perform a further in-depth analysis
using several extraction tools:
– Distiller SR, where extraction forms will be used to
note demographic and numeric values as well as for
performing quality assessment.
– Nvivo11, where textual data will be extracted.
– JMP (JMP®, Version 12. SAS Institute Inc., Cary, NC,
1989-2015.), or another statistical analysis software,
will be used for the meta-analysis.
Selection of studies
All articles will be classified and categorized in the phase
I scoping review. For phase III, all studies from phase I
that were categorized as RCTs that report on measured
outcomes of CEC will be included. All non-quantitative
studies will be excluded. For mixed-method studies, the
quantitative component may be used if it is determined
to be comparable to a RCT. Trial studies that are not
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RCTs may be included if they measure similar clinical
outcomes as the RCTs.
Assessment of risk of bias in included studies
Study quality will be assessed using the Critical Appraisal
Skills Programme (CASP) questions [59]. Two reviewers
(LL, AM) will independently evaluate studies using the
CASP checklist. Where disagreements in any of the evalu-
ations exist, reviewers will consult with content experts
(JA, MW, JG, KF) for resolution.
Next, the Grades of Recommendation, Assessment, De-
velopment, and Evaluation (GRADE) approach from the
Cochrane Collaboration will also be used to assess in-
cluded studies [24]. This will also be built into a checklist
for evaluation of the five areas of (1) risk of bias, (2) in-
consistency, (3) indirectness, (4) imprecision, and (5) pub-
lication bias [24, 60]. Confidence will be judged as high,
moderate, low, or very low. Exclusions based on quality
will be made following Cochrane standards [24].
Assessment of reporting biases
If sufficient studies are found to perform a meta-
analysis, funnel plots will be used to assess for publica-
tion bias. Reported outcomes and comparisons will be
matched to the study protocol, where available, to assess
for reporting bias.
Measure of treatment effect
The types of data handled for the phase II synthesis will
follow Cochrane standards [24].
– Continuous data
When the same scales/units are used, mean differences
will be calculated. When differing scales/units are used,
standardized mean differences will be used. These will
be reported with 95 % confidence intervals.
– Dichotomous data
Risk ratios will be calculated for dichotomous
(binary) data. These will be reported with 95 %
confidence intervals. If it is more appropriate, odds
ratios may be converted to standardized mean
differences. Where appropriate results from different
trials will be combined.
– Ordinal data
Ordinal outcomes will be treated as continuous
variables or dichotomous variables, depending on
thresholds.
– Count data
For events experienced between two groups that use
count data, rate ratios will be calculated.
Unit of analysis issues
For RCTs and other studies where randomization was
used, ICC estimates will help in examining design effect
where the variance may be inflated accordingly. If ICC is
not readily available, authors may be contacted. Other-
wise, trials may be analyzed using imputed ICC estimates
from similar trials and where sensitivity analysis can be
performed. In order to account for clustering, authors
may be contacted to expand on how causal treatment ef-
fect and organizational clustering were separated.
Dealing with missing data
For quantitative studies, when study data are missing,
authors will be contacted. All missing data will be re-
corded for later reporting if study authors cannot pro-
vide missing data (or if they do not respond). The
quantity and patterns, as well as the handling of missing
data, will be recorded. Sensitivity analysis may be per-
formed to assess the impact of missing data, which will
be addressed in any summary of findings.
Assessment of heterogeneity
Heterogeneity of trial studies will be assessed by percent-
age of total variation (I2 statistic). Heterogeneity will be
assessed using forest plots, chi2 (P < 0.10), and I2 tests
(low is <49 %, moderate is 50 to 74 %, high is 75 to
100 %). If there is moderate heterogeneity (chi2 P < 0.10
AND I2 moderate-to high), we will use a random-effects
model [24]. If there is no statistical heterogeneity (low I2),
we will combine results using a fixed-effect model.
Subgroup analysis and investigation of heterogeneity
Using an I2 statistic, heterogeneity across subgroups will
be analyzed. If data allow, and if it seems helpful in illu-
minating relationships, a multivariate meta-regression
model based on outcomes may be performed.
Sensitivity analysis
If components of a study give disproportionate influence
to the review, sensitivity analyses will be performed and
will be reported in a “summary of findings” table.
Presentation of data
A “summary of findings” table will be presented for the
quantitative synthesis as well as a forest plot, if possible.
There will also be textual and visual depictions of find-
ings to help explain the findings generated from the
literature.
A comprehensive list of the steps of the synthesis will be
reported either in text or as an appendix for comparison to
this protocol. A PRISMA checklist and diagram will be pro-
vided to compare to the PRIMSA-P checklist provided in
appendix to this article (see Additional file 2) [51–54].
Discussion
The literature on CEC is wide ranging and includes both
quantitative and qualitative work. Relatively little of this
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literature addresses quality measurement explicitly, but a
rather large number of articles and reports implicitly de-
scribe issues related to CEC quality and how to measure it.
We have developed a protocol to accomplish a formal
systematic review of this diverse literature that will list
possible quality measures for CEC found in the included
articles, develop categories for these measures (i.e., qual-
ity domains) comprising an analytical structure for
measuring the quality of CEC, and assess the effects of
CEC on clinical outcomes. This mixed-methods review
will fill a major gap, as there have been no formal efforts
to analyze and synthesize the complete literature on
CEC to seek latent consensus around potential quality
measures and domains. The protocol we have described
will apply a quality assessment lens to this diverse litera-
ture, which will contribute to the evolution of theories
about quality measurement for CEC and, more import-
antly, might stimulate the development and dissemin-
ation of useful CEC quality measures.
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